CAS 1640294-30-9

(6-(1-((6-Methoxypyridin-3-yl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2-yl)(4-(4-(trifluoromethyl)benzyl)piperazin-1-yl)methanone bis(4-methylbenzenesulfonate)

CAS : 1640294-30-9

Formule : C₄₆H₅₁F₃N₆O₈S₂

Degré de pureté : 97%

Masse moléculaire : 937.0577

Ref: IN-DA01V4KS

(6-(1-((6-Methoxypyridin-3-Yl)Methyl)Piperidin-4-Yl)-1H-Benzo[D]Imidazol-2-Yl)(4-(4-(Trifluoromethyl)Benzyl)Piperazin-1-Yl)Methanone Bis(4-Methylbenzenesulfonate)

CAS : 1640294-30-9

(6-(1-((6-Methoxypyridin-3-Yl)Methyl)Piperidin-4-Yl)-1H-Benzo[D]Imidazol-2-Yl)(4-(4-(Trifluoromethyl)Benzyl)Piperazin-1-Yl)Methanone Bis(4-Methylbenzenesulfonate)

Degré de pureté : 97%

Masse moléculaire : 937.06g/mol

Ref: 54-PC108668

ASP4132

CAS : 1640294-30-9

ASP4132

Degré de pureté : ≥98%

Masse moléculaire : 937.06g/mol

Ref: 54-BUP04008

ASP4132

CAS : 1640294-30-9

ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.

Formule : C₄₆H₅₁F₃N₆O₈S₂

Degré de pureté : 98.34%

Couleur et forme : Solid

Masse moléculaire : 937.06

Ref: TM-T8432

ASP4132

CAS : 1640294-30-9

ASP4132 is a small molecule that has been shown to induce cell death in tumor cells through autophagy. It is orally active and can be used as a chemotherapeutic agent. ASP4132 activates the AMP-activated protein kinase, which inhibits the mTORC1 complex, leading to an increase in autophagy and apoptosis. The oral bioavailability of this drug is high and it has been shown to have limited toxicity. Clinical development for this drug is ongoing with toxicities such as anorexia, weight loss, dehydration, and elevated liver enzymes observed.

Formule : C₄₆H₅₁F₃N₆O₈S₂

Degré de pureté : Min. 95%

Masse moléculaire : 937.06 g/mol

Ref: 3D-QQC29430